Let Activefol.io Invest in REGN on Your Behalf.
- Active Investing
- Personalized Strategy
- Low Monthly Fees
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
What is Activefol.io?
Activefol.io, our automated portfolio management platform, is designed to manage individual portfolios using the latest technology. Its proprietary system is designed to screens, monitors and invest in elite stocks like "REGENERON PHARMACEUTICALS, INC. (REGN)" using is unique Artificial Intelligence signals. It is designed to augment investors profit potential.
Activefol.io produces short-term trades which makes it an ideal tool for investing in tax-deferred accounts such as IRAs and Roth IRAs. If also works great in individual and joint taxable accounts. Just be aware that Activefol.io produces short-term investments that can be taxed at different rates than long-term investments. Make sure you understand your tax situation before using Activefol.io.
Using Activefol.io is easy. It connects to your account located at one of our supported Broker / Dealers. Our current Partners are offering brokerage services in the United States only. You will need a minimum of $25,000 deposited in your account, enable your margin to allow continuous investing to take place. Once enabled, Activefol.io will start working on your behalf.
There are clear benefits associated with using an automated portfolio management system such as Activefol.io to help you reach your financial goals. Activefol.io simplifies stock investing down to a few easy steps. It invests for you, using your personalized strategy, while you attend more important life events.
Using Activefol.io feels like having a professional Portfolio Manager working for you to help you reach your financial goals.
Activefol.io actively invests in the most positive components of the S&P 500® on your behalf. Its Artificial Intelligence signal takes into account emotional and rational indicators to provide key intelligence, 24/7. It 'trades on the news' taking advantage of price changes and trends by listening to market changes.
Activefol.iois one of the first automated management platforms to take advantage of Government grade listening technology. It consumes market data and other specialized data feeds natively to produce a dynamic picture of the market.
Try Activefol.io today!
You can test Activefol.io in simulation mode, risk free, Stock Circles today.
Get started now - and see where active automated trading can take you.
Disclaimer: Past performance may not be indicative of future results. ACTIVEFOL.IOg, like other investment methods, rely on favorable market conditions to provide positive returns.
REGENERON PHARMACEUTICALS, INC. (REGN) News
Zoetis teams up with Regeneron to discover new vet treatments
Regeneron Pharmaceuticals (NASDAQ:REGN) and Zoetis (NYSE:ZTS) enter into a five-year collaboration aimed at discovering new veterinary treatments based on Regeneron's monoclonal antibodies.
Under the terms of the agreement, Zoetis will in-license Regeneron's VelocImmune antibody technology that it will use to develop monoclonal antibodies modified for species-specific use in companion and livestock animals. Top focus areas will be allergic and immune-related conditions, pain, inflammatory disease and cancer. Regeneron will also select certain pipeline candidates for Zoetis to evaluate in dogs and cats with naturally occurring disorders like osteoarthritis.Get Started today! - Risk Free